Neoadjuvant hormone therapy for radical prostate radiotherapy:bicalutamide monotherapy vs. luteinizing hormone-releasing hormone agonist monotherapy: a single-institution matched-pair analysis
| Data(s) |
01/09/2012
|
|---|---|
| Resumo |
The purpose of this study was to compare the prostate-specific antigen (PSA) response to either neoadjuvant bicalutamide (BC) monotherapy or neoadjuvant luteinizing hormone-releasing hormone agonist (LHRHa) monotherapy and the subsequent effect on biochemical failure-free survival (BFFS) in men receiving radical radiotherapy (RT) for localized prostate cancer. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
McGivern , U , Mitchell , D M , McDowell , C , O'Hare , J , Corey , G & O'Sullivan , J M 2012 , ' Neoadjuvant hormone therapy for radical prostate radiotherapy : bicalutamide monotherapy vs. luteinizing hormone-releasing hormone agonist monotherapy: a single-institution matched-pair analysis ' Clinical genitourinary cancer , vol 10 , no. 3 , pp. 190-5 . DOI: 10.1016/j.clgc.2012.04.003 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology #/dk/atira/pure/subjectarea/asjc/2700/2748 #Urology |
| Tipo |
article |
